Welcome to the Komen Health Equity Revolution podcast series. Each month, we invite in patients, community organizations, health care providers, researchers and policy advocates to discuss strategies and solutions that drive the health equity revolution forward for multiple populations experiencing breast health inequities.

In honor of Black History Month, this Komen Health Equity Revolution episode of the Real Pink podcast takes a deep dive into the unique challenges and disparities Black women face in breast cancer care. Joining me is Komen Scientific Advisory Board member Dr. Lisa Newman, a trailblazing breast surgical oncologist and researcher. In this episode, we’ll explore the lack of representation of Black bodies in the medical space and its impact on care and treatment. We’ll also discuss culturally responsive care, the transformative role of diverse health care providers, and ways to advocate for yourself as a patient. Let’s dive into this important conversation.

Breast cancer treatment today is becoming more personalized and more precise. Precision medicine is rapidly expanding the options patients have for treating their cancer while helping them maintain a desired quality of life. A common mutation in breast cancer called PIK3CA affects more than 1 in 3 people with breast cancer, making it harder to treat. This mutation often leads to worse outcomes for these patients compared to others. Scientists are now developing new treatments that target this mutation specifically, aiming to reduce side effects and improve treatment outcomes, such as shrinking tumors or preventing disease progression.

Today, we are speaking with Dr. Sarah Sammons of Dana-Farber Cancer Institute to explore the exciting new possibilities brought by personalized medicine, including whether it can help slow disease progression and how it can it improve patients’ abilities to potentially live more active and productive lives while on treatment.

This is Real Talk, a podcast conversation where we’re digging deep into breast cancer and the realities patients and survivors face every day. We’re talking openly and honestly about just how difficult breast cancer can be, from being diagnosed to selecting the right treatment plan, to living day to day with metastatic breast cancer, and life after treatment ends.

  In today’s episode, we’re talking about the effect treatment has on sexual health and unwanted side effects women face during breast cancer treatment and life thereafter. Joining us today are Jenn Smith and Nisha Jaime. Jenn is 42 years old, and a 3-year breast cancer survivor. She and her husband have been married for 17 years. Nisha is 45 years old and a 1-year breast cancer survivor. She is also married with 3 school-aged children.

Both women are learning to live with the impact breast cancer treatment is having on their bodies, their intimacy and their overall wellbeing.

As we kick off Black History Month here on Real Pink, we’re excited to highlight guests who have been affected by breast cancer and are using their experiences to make an impact. Today’s guest advocated for herself to ensure that she was receiving the best, most personalized treatment for her after her diagnosis, and in the process learned the staggering fact that less than 10% of clinical trial participants are members of racial or ethnic communities who often face higher breast cancer or mortality rates. This fueled Tina Pickett to get involved. She is passionate about educating women on early detection, health equity and representation in research and her team was at the top of the fundraising board at her local Race for the Cure.

Tune into the latest episode of Real Pink for a vital conversation about the transformative impact of personalized care, its role in addressing disparities and how it can empower patients in their breast cancer journey. Dr. Ezinne Ihenachor, a diagnostic radiologist and passionate health equity advocate, helps us understand how personalized care can address systemic inequities and improve outcomes for all.

Thanks to Merck for supporting the Real Pink Podcast.

Tamoxifen is a medication used to block estrogen, which is needed for some breast tumors to grow. Many survivors are prescribed tamoxifen to lower the risk of having a recurrence of breast cancer, usually after breast cancer surgery, chemotherapy and radiation. Tamoxifen can also be used for breast cancer risk reduction in women who do not have breast cancer but who are at higher risk, which was the case with today’s guest. Twenty years after her mother passed away from breast cancer, Colleen Boraca learned she had two conditions that increase her chances of developing breast cancer. At the recommendation of her oncologist, she began her five-year, daily journey with Tamoxifen and is here today to share about her experience, what helped her get through struggles and how she was able to work with her doctor along the way to get the personalized care that was right for her.

This is Real Talk, a podcast conversation where we’re digging deep into breast cancer and the realities patients and survivors face every day. We’re talking openly and honestly about just how difficult breast cancer can be, from being diagnosed to selecting the right treatment plan, to living day to day with metastatic breast cancer, and life after treatment ends.

In today’s episode, we’re talking about getting a second opinion and why that’s so important when selecting your treatment plan. Our guests today, Shilo Goodman and Eve Laidacker, both had to speak up and tell their doctors they didn’t agree with their medical advice, and advocated for what they thought was best for themselves.

On today’s show, we are joined by two sisters, who are unfortunately no strangers to breast cancer. Their biological mother passed away from metastatic breast cancer when she was 52. While they were aware that their mother’s diagnosis put them at a higher risk, it still came as a shock when Tami Salawater was diagnosed at the age of 50. Two weeks later, her younger sister Jamie Boettcher received her own breast cancer diagnosis. Both women were diagnosed at an early stage, but with different types of cancer and they each faced unique challenges and side effects as they navigated their treatments. Jamie and Tami are here today to share their story of facing breast cancer together as a family and the personalized care that each of them received.

Understanding your family health history can help you take better care of your health by helping to figure out your risk and take action as needed. Joining us on the show today is Jerry Carnes, a former television journalist who spent 35 years with 11Alive in Atlanta. He has an extensive family history of cancer in his family, has lost multiple family members to both breast and prostate cancers and is a prostate cancer survivor himself. Jerry is here to share his story and to spread education on the importance of knowing your family history and taking charge of your health by getting regular screenings and promoting early detection. His hope is that by that sharing his family’s experience, he can help to prevent other families from going through a similar situation.

To advance health equity in breast cancer care, Komen believes that everyone should have a just opportunity to be as healthy as possible despite their cultural or demographic background. That is why Komen is committed to eliminating barriers to care for individuals and communities experiencing breast health inequities now and in the future. We are honored to be joined on today’s show by two members of Komen’s Community Health Outreach team, women who drive this important work every day. Natasha Mmeje and Theru Ross are here to share some details of Komen’s good work in breast health equity this year and what their hopes are for the future.